Omega Fund VI, L.P. files SEC Form 4 disclosures for Imago BioSciences, Inc.. They have made 1 open-market trade across 1 company since 2021, most recently 2021-07-20.
CIK 0001757917
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.0M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMGO | 2,525,909 | $91.0M |
Shares reported on the most recent Form 4, priced at the 2021-07-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMGO | BUY | 2021-07-15 | 2021-07-19 | $16.00 | $4.0M | +5.0% | +23.5% | +46.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.